Author:
Chen Huixin,Xiang Siying,Huang Ling,Lin Jiajia,Hu Shengquan,Mak Shing-Hung,Wang Chuang,Wang Qinwen,Cui Wei,Han Yifan
Funder
National Natural Science Foundation of China
Applied Research Project on Nonprofit Technology of Zhejiang Province
Ningbo international science and technology cooperation project
Ningbo municipal innovation team of life science and health
Guangdong Provincial International Cooperation Project of Science & Technology
Shenzhen Basic Research Program
Guangdong-Hong Kong Technology Cooperation Funding Scheme
Research Grants Council of Hong Kong
Hong Kong Polytechnic University
LiDakSum Marine Biopharmaceutical Development Fund, and the K. C. Wong Magna Fund in Ningbo University.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Biochemistry
Reference35 articles.
1. Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res 36:375–399
2. Bajda M, Guzior N, Ignasik M, Malawska B (2011) Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 18:4949–4975
3. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377:1019–1031
4. Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Melchiorre C (2008) From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease. Mini Rev Med Chem 8:960–967
5. Camps P, Cusack B, Mallender WD, el Achab RE, Morral J, Muñoz-Torrero D, Rosenberry TL (2000) Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease. Mol Pharmacol 57:409–417
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献